Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer

Although Bacillus Calmette-Guérin (BCG) is the most successful immunotherapy for high-risk non-muscle-invasive bladder cancer, approximately 30% of patients are unresponsive to treatment. New biomarkers are important to identify patients who will benefit most from BCG during a worldwide BCG shortage...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, Renate, Fritz, Josef, Zavadil, Claudia, Schäfer, Georg, Culig, Zoran, Brunner, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129981/
https://www.ncbi.nlm.nih.gov/pubmed/27221038
http://dx.doi.org/10.18632/oncotarget.9537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129981/
https://www.ncbi.nlm.nih.gov/pubmed/27221038
http://dx.doi.org/10.18632/oncotarget.9537

Ejemplares similares